Prevalence and Associated Factors of Metabolic Syndrome among Patients with Severe Mental Illness Attending a Tertiary Hospital in Southwest Uganda

Table 4

Clinical factors associated with MetS at bivariate analysis.

Characteristic	% of MetS	Bivariate analysis	value
	n/N (%)	OR (95% CI)
HIV status
Negative	63 (88.73)	Ref
Positive	08 (11.27)	1.00 (0.43–2.32)	0.998
Mental illness
BAD	46 (64.79)	Ref
Schizophrenia	18 (25.35)	0.94 (0.50–1.74)	0.836
Depression	07 (9.86)	0.93 (0.37–2.29)	0.867
Duration of mental illness (years)
<5	24 (33.80)	Ref
5–10	09 (12.68)	0.72 (0.32–1.66)	0.446
>10	38 (53.52)	3.11 (1.71–5.68)	<0.001
Duration of psychotropic medication (years)
<5	28 (39.44)	Ref
5–10	33 (46.48)	2.55 (1.40–4.62)	0.002
>10	10 (14.08)	0.75 (0.34–1.64)	0.465
Antipsychotic
No	15 (21.13)	Ref
Yes	56 (78.87)	0.78 (0.40–1.52)	0.468
Antipsychotic class
Typical	50 (89.29)	Ref
Atypical	06 (10.71)	2.42 (0.82–7.14)	0.107
Mood stabilizer
No	37 (52.11)	Ref
Yes	34 (47.89)	0.75 (0.44–1.28)	0.296
Antidepressant
No	53 (74.65)	Ref
Yes	18 (25.35)	1.72 (0.91–3.26)	0.094
Level of physical activity
<150 min of moderate exercise or 75 min of vigorous/ week	65 (91.55)	Ref
≥150 min of moderate exercise or 75 min of vigorous/ week	06 (8.45)	0.80 (0.31–2.03)	0.633

Note. BAD: bipolar disorder; MetS: metabolic syndrome; hx: history; OR: odds ratio; CI: confidence interval; Ref: reference category.